Abreva side effects, by duration, gender and age (a phase IV clinical study of FDA data)
Summary:
Side effects are reported by people who take Abreva (docosanol). Common side effects include drug ineffective among females and drug ineffective among males.
The phase IV clinical study is created by eHealthMe based on 17,058 reports from the FDA, and is updated regularly.
What is Abreva?
Abreva has active ingredients of docosanol. It is often used in herpes labialis (oral herpes simplex). eHealthMe is studying from 17,071 Abreva users. Check the latest studies of Abreva.
17,058 people who take Abreva and have side effects are studied.
What are the common side effects of Abreva, by gender? *
What are the common side effects of Abreva, by age (0-1 to 60+)? *
What are the common side effects of Abreva, by the time people have been on the drug (< 1 month to 10+ years)? *
* Approximation only. Some reports may have incomplete information.
Do you take Abreva?
- Personalize this study to your gender and age- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
How the study uses the data?
The study is based on docosanol (the active ingredients of Abreva) and Abreva (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Related studies are listed below in case you need more information:
Alternative drugs to, pros and cons of Abreva:
- Abreva (17,071 reports)
All Abreva side effects from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zWho is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Amaryl cause Cardiac Tamponade? - 2 seconds ago
- Could Clozaril cause Ideas Of Reference? - 13 seconds ago
- Drug interactions of Pregabalin and Doxil - 22 seconds ago
- Could Lipidil cause Diarrhea Aggravated? - 25 seconds ago
- Rheumatoid Arthritis and Acute Upper Airway Obstruction - 28 seconds ago
- Drug interactions of Hydroxyzine Hydrochloride and Budesonide - 52 seconds ago
- Could Requip cause Injection Site Swelling? - a minute ago
- Drug interactions of Nadolol and Welchol - a minute ago
- Could Fentanyl cause Nephropathy Toxic? - a minute ago
- Could Vasotec cause Drug Intolerance? - a minute ago